Technical Advisory Board

Stefan Ståhl
Professor at Royal Institute of Technology (KTH), co-founder of Affibody.

Sophia Hober
Professor at Royal Institute of Technology (KTH), co-founder of Affibody.

Vladimir Tolmachev
Professor at Uppsala University.

Anna Orlova
Associate Professor at Uppsala University.

John Löfblom
Assistant Professor at Royal Institute of Technology (KTH).

Torbjörn Gräslund
Professor at Royal Institute of Technology (KTH).

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Upcoming reports Financial calendar

  • Interim Report Q2 (August 23, 2018)